Once tipped as blockbusters, Praluent and a rival PCSK9 drug from Amgen – Repatha (evolocumab) – have struggled to gain sales momentum in the much larger population of people with other forms ...

Repatha evolocumab is a form of treatment for cardiovascular diseases. It works by lowering LDL cholesterol levels, hence reducing the risk of heart attacks, strokes, and other cardiovascular ...

The company’s Repatha (evolocumab) was added to optimised statin therapy in a phase 3 trial, and resulted in statistically significant regression of atherosclerosis in patients with coronary ...

Repatha works by blocking a specific enzyme in your liver to help your body remove cholesterol more effectively. It doesn’t work by suppressing the immune system, but as a side effect, it can ...

Read the instructions carefully and complete the application form. Step 5: Fill in the required information and pay the required category-wise application fees. Step 6: Submit the application form ...

A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...

PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) is focused on the development and commercialization of KETARX™ (Ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

LIB Therapeutics Inc. (LIB), a privately-held, late-stage biopharmaceutical company today announced the U.S. Food and Drug Administration (FDA) has ac ...

The price you pay for Livalo may depend on factors such as your insurance and the pharmacy you use. Financial assistance may be available to help you with the cost of this medication. your ...

The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and Valsartan tablets for heart failure patients. Sacubitril and Valsartan ...

We assess each application individually and decide whether the content ... we get the information we need directly from your UCAS form. More information about contextual offers. You may need to ...